Pharmaceutical manufacturer Eli Lilly announced in the third quarter of 2009 that it was taking a $425

Question:

Pharmaceutical manufacturer Eli Lilly announced in the third quarter of 2009 that it was taking a $425 million restructuring charge due to the sale of its Tippecanoe Laboratories unit. Of the total expense, the company indicated that $364 million was related to “non-cash” asset impairment charges, with $61 million coming from severance packages for certain Tippecanoe employees. The third quarter 2009 statement of cash flows (operating section) contains a line item added back to net income for “other, net” in the amount of $364 million.

REQUIRED:

a. Provide the entry made by Lilly to record the charge.

b. Explain why the statement of cash flow contained the $364 million entry.

c. Assume Lilly’s tax rate for 2009 was 26 percent. Compute the tax savings related to the charge.


Fantastic news! We've Found the answer you've been seeking!

Step by Step Answer:

Related Book For  book-img-for-question
Question Posted: